2024 DHA CPC: Drug Therapy for Obesity Management
Target Audience
This activity provides continuing education for pharmacists and pharmacy technicians. A certificate of attendance is available for other attendees.
Learning Objectives
1. Summarize the current guideline recommendations for weight loss management.
2. Evaluate the current evidence supporting use of each class of anti-obesity medication.
3. Describe the prior authorization process for anti-obesity medications under Tricare formulary.
4.Apply a weight loss management plan incorporating lifestyle intervention and pharmacotherapy for a patient who is a candidate for anti-obesity medication.
Jennifer Kim, Pharm.D., B.C.A.C.P., B.C.A.D.M. Presenter has no financial or non-financial relationships to disclose. Dr. Kim will discuss off-label uses for the following medications: bupropion (Actavis), naltrexone(Accord), topiramate(Par)
Kelly Campbell, Pharm.D., B.C.P.S. Presenter has no financial or non-financial relationships to disclose. Dr. Campbell will discuss off-label uses for individual components of Qsymia and Contrave for weight management
Disclosure: DHA J-7 staff, Planning Committee Members and reviewers have no financial or non-financial interest to disclose. All faculty members have no financial or non-financial interest to disclose.
Available Credit
- 1.50 Pharmacists (ACPE)JA4008136-0000-24-201-L01-P
No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 1.50 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity. - 1.50 Pharmacy Technicians (ACPE)JA4008136-0000-24-201-L01-T
No valid paper/electronic statement of credit will be offered. DHA, J-7, CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 1.50 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
- 1.50 Certificate of Attendance
Access Codes: Some courses require an access code to register. Please reach out to the point of contact at the organization providing the activity for the registration code. The Continuing Education Program Office (CEPO) does not provide access codes.
Accommodations: CEPO provides captions and transcripts to hearing-impaired learners upon request. For real-time closed captioning, contact CEPO at least three (3) business days before the event. If we cannot arrange for live captioning, a video recording and audio transcript will be provided after the event, typically within ten business days. For events delivered by CEPO’s partners, please contact the course instructor to inquire about accommodations.
For more details, or to submit a request, email [email protected].